GJK PHARMA LTD.
Significant control: Karen Kilpatrick (50–75%), Gavin John Kilpatrick (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Gjk Pharma Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Gjk Pharma Ltd. sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
GJK PHARMA LTD. is an active private limited company (company number 07621723) incorporated on 4 May 2011, registered in St. Neots. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 August 2025, showing net assets of £78k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 60% on the prior period (£195k).
By net assets it sits in the top quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
Ownership and control
- Mrs Karen Kilpatrick
- owns 50–75% of shares
- holds 50–75% of voting rights
- Dr Gavin John Kilpatrick
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 4 May 201115 yrs ago
- Next accounts due
- 31 May 2027in 218 days
- Confirmation statement due
- 18 May 2027in 205 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £78k | — | — | £2,582 | — | — | 2 |
| 31 August 2024 | £195k | — | — | £4,589 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £78,105 at 31 August 2025
- Net assets down 25% or more on the prior period-60.0% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 25.75
- Incorporated five or more years agoIncorporated 4 May 2011
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 218 days
- Confirmation statement duein 205 days
- Accounts period endNet assets £78k · micro accounts
- Accounts period endNet assets £195k · micro accounts
- Incorporated
Similar companies in the UK
- NEUREXPERT LIMITEDExeter · inc. May 2011
- CCM TECHNOLOGIES LIMITEDSwindon · inc. May 2011
- MOLECULAR RESEARCH LIMITEDExeter · inc. May 2011
- MATDOC LTDYork · inc. May 2011
- PRECISION HYDRATION LIMITEDChristchurch · inc. Apr 2011
- SMARTCARE WORLDWIDE LIMITEDTring · inc. Jun 2011
All companies incorporated on 4 May 2011 · in May 2011.
Reminders for GJK PHARMA LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.